Norrbottnian Gaucher Disease
Links shared publicly online about this topic
NGF - Gaucher Disease Awareness Month
gaucherdisease.org — “My name is Karina V?squez Fuentes. I am 29 and I suffer from Gaucher Disease” View full resource at gaucherdisease.org
Most Recently Shared on October 28, 2011 at 2:30 pm By:
October is Gaucher Awareness Month. To better understand this rare disease, read Karina Vásquez Fuentes’s story: http://t.co/Gq5WZBnJ
Gaucher disease: FDA approves VPRIV
news-medical.net — “The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease.” View full resource at news-medical.net
Most Recently Shared on February 27, 2010 at 4:57 am By:
Stroke News: Gaucher disease: FDA approves VPRIV: The U.S. Food and Drug Administration has approved velaglucera... http://twurl.nl/zaidct
FDA Approves VPRIV to Treat Gaucher Disease
drugs.com — “VPRIV (velaglucerase alfa) is used to treat Gaucher disease. Includes VPRIV side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 28, 2010 at 5:02 am By:
FDA Approves VPRIV to Treat Gaucher Disease - http://bit.ly/dATgn7
Elelyso Approved for Gaucher Disease --Doctors Lounge
doctorslounge.com — “Elelyso Approved for Gaucher Disease --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on May 2, 2012 at 4:14 am By:
Elelyso Approved for Gaucher Disease http://t.co/Xbc54SZp #health #medicine
Gastro Medical News about Gaucher Disease
mdlinx.com — “The US Food and Drug Administration Approves a New Gaucher Disease Drug” View full resource at mdlinx.com
Most Recently Shared on June 8, 2010 at 7:54 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The US Food and Drug Administration Approves a New Gaucher Disease Drug: Gastroenterology http://bit.ly/d1S9dg #GI
FDA Approves Therapy To Treat Gaucher Disease
tweetmeme.com — “The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease. Gaucher disease occurs in people who do not produce enough of an enzy” View full resource at tweetmeme.com
Most Recently Shared on February 27, 2010 at 2:49 pm By:
Healthcare TweetMeme Health Social Media
FDA Approves Therapy To Treat Gaucher Disease http://retwt.me/1MjGN (via @healthytweet)
Vpriv available for Type 1 Gaucher disease - ONA
oncologynurseadvisor.com — “Shire announced that Vpriv (velaglucerase alfa for injection) has been FDA approved and made available for the treatment of Type 1 Gaucher disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 1, 2010 at 4:13 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Vpriv available for Type 1 Gaucher disease http://goo.gl/fb/3kQb
Phase II Study Of An Oral Therapy For Gaucher Disease Yields Positive Results
medicalnewstoday.com — “Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a” View full resource at medicalnewstoday.com
Most Recently Shared on May 5, 2010 at 12:18 pm By:
MNT Clinical Trials Health News
Phase II Study Of An Oral Therapy For Gaucher Disease Yields Positive Results http://mnt.to/3C85 #clinicaltrials
OnePath Gaucher Application available for patients with Type 1 Gaucher disease
news-medical.net — “Shire plc, the global specialty biopharmaceutical company, today announced the availability of the OnePath Gaucher Application. The first and only application developed specifically for patients in the U.S. with Type 1 Gaucher disease, it is free and ready for download at the iTunes Application store.” View full resource at news-medical.net
Most Recently Shared on May 24, 2010 at 2:12 pm By:
OnePath Gaucher Application available for patients with Type 1 Gaucher disease: Shire plc, the global specialty bi... http://bit.ly/9enDrk
Oral therapy for Gaucher disease: Study yields positive results
sciencedaily.com — “Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a new study, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.” View full resource at sciencedaily.com
Most Recently Shared on May 3, 2010 at 9:30 pm By:
Oral therapy for Gaucher disease: Study yields positive results: Gaucher disease, a rare enzyme deficiency disorde... http://bit.ly/bEUKir
Cheaper, More Effective Treatment of Type 1 Gaucher Disease Possible
opa.yale.edu — “Cheaper, More Effective Treatment of Type 1 Gaucher Disease Possible” View full resource at opa.yale.edu
Most Recently Shared on October 20, 2010 at 4:21 pm By:
School of Medicine Medical School
New light on Type 1 Gaucher Disease: http://bit.ly/9KneM0
Elelyso Approved for Type 1 Gaucher Disease --Doctors Lounge
doctorslounge.com — “Elelyso Approved for Type 1 Gaucher Disease --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on May 2, 2012 at 12:04 am By:
Elelyso Approved for Type 1 Gaucher Disease http://t.co/s2NSsCih #Health #Medicine
Phase 2 Trial Update of Eliglustat for the Treatment of Gaucher Disease - MPR
empr.com — “Genzyme announced four-year follow-up data from its Phase 2 clinical trial of eliglustat tartrate for the treatment of Gaucher disease type 1.” View full resource at empr.com
Most Recently Shared on February 8, 2012 at 8:35 pm By:
Phase 2 Trial Update of Eliglustat for the Treatment of Gaucher Disease http://t.co/cYnJCTvf #hematology
Phase II study of an oral therapy for Gaucher disease yields positive results
physorg.com — “Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat ...” View full resource at physorg.com
Most Recently Shared on May 3, 2010 at 9:40 pm By:
PhysOrg Health News Health News
Phase II study of an oral therapy for Gaucher disease yields positive results http://tw.physorg.com/192124667
Cheaper, more effective treatment of type 1 Gaucher disease possible
labspaces.net — “Researchers at Yale School of Medicine have found that new disease pathways involving more than one cell type leads to Type 1 Gaucher disease, a rare genetic disorder in which fatty substances called glycosphingolipids accumulate in cells, resulting in liver/spleen enlargement, osteoporosis, bone pain, and increased risk of cancer and Parkinson's disease.” View full resource at labspaces.net
Most Recently Shared on October 20, 2010 at 5:20 pm By:
Cheaper, more effective treatment of type 1 Gaucher disease possible - http://is.gd/g9XvV
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Genzyme Corporation
The official Twitter site of Genzyme Corporation.
-
News-Medical.Net
Stay up to date with the latest Stroke news and research via News-Medical.Net
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
